Soriatane is an oral retinoid medication used primarily for the treatment of severe psoriasis. It functions by modulating the activity of nuclear receptors that control skin cell growth and differentiation. After oral administration the drug is absorbed and converted to active metabolites that bind to retinoic acid receptors. Binding to these receptors alters transcription of genes involved in keratinocyte proliferation and immune signaling. This regulation reduces excessive skin cell turnover and inflammation characteristic of psoriatic lesions. The pharmacodynamic effect of Soriatane leads to a slower but more sustained improvement in skin appearance. The overall mechanism involves alteration of cellular processes that restore normal skin architecture.

Soriatane is an oral retinoid medication used in the treatment of certain skin conditions. It belongs to the class of compounds derived from vitamin a and works by modulating cellular differentiation and growth. The drug acts by binding to nuclear receptors that regulate gene expression involved in skin cell turnover. Through this interaction Soriatane helps normalize the overproduction of keratinocytes and reduces inflammatory signaling. Its therapeutic role includes improving the appearance of lesions and promoting long-term remission of disease activity. The pharmacological activity is characterized by a gradual effect that accumulates with continued dosing over weeks to months. By influencing pathways that control cell proliferation and immune modulation the medication restores normal skin architecture. Overall Soriatane provides a targeted approach to managing disease symptoms without directly addressing underlying infections or allergies.

The most common side effects are usually mild and short lived. Headache often appears in the first few days. Some people experience a feeling of nausea. Fatigue can occur without a clear cause. Mild skin redness may appear at the injection site. Dizziness sometimes accompanies other symptoms.

The most common side effects are mild headache, fatigue, nausea, dizziness, dry mouth, low grade fever, and occasional skin rash. These reactions are usually transient and resolve without intervention. They occur in a modest proportion of users across various age groups. Incidence rates are generally low compared to therapeutic benefits. Most episodes do not require medical attention and improve over time. Patterns of occurrence are similar across different formulations and dosing schedules. Awareness of these effects helps patients recognize typical responses.